61 related articles for article (PubMed ID: 37522200)
21. Chromosome instability region analysis and identification of the driver genes of the epithelial ovarian cancer cell lines A2780 and SKOV3.
Li J; Chen Z; Xiao W; Liang H; Liu Y; Hao W; Zhang Y; Wei F
J Cell Mol Med; 2023 Nov; 27(21):3259-3270. PubMed ID: 37525498
[TBL] [Abstract][Full Text] [Related]
22. ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis.
Wang X; Peng H; Zhang G; Li Z; Du Z; Peng B; Cao P
BMC Med Genomics; 2023 Jul; 16(1):178. PubMed ID: 37525242
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel 5-methylcytosine-related signature for prognostic prediction of kidney renal papillary cell carcinoma and a Putative target for drug repurposing.
Zhang Z; Cao C; Zhou CL; Li X; Miao C; Shen L; Singla RK; Lu X
Transl Oncol; 2023 Oct; 36():101741. PubMed ID: 37523897
[TBL] [Abstract][Full Text] [Related]
24. Construction of a two-gene prognostic model related to ferroptosis in renal cell carcinoma.
Li L; Xu Y; Yang W; Zhang K; Zhang Z; Zhou J; Gong Y; Gong K
Transl Androl Urol; 2023 Jul; 12(7):1167-1183. PubMed ID: 37554538
[TBL] [Abstract][Full Text] [Related]
25. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].
Qu SQ; Pan LJ; Qin TJ; Xu ZF; Li B; Wang HJ; Sun Q; Jia YJ; Li CW; Cai WY; Gao QY; Jiao M; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):373-379. PubMed ID: 37550186
[No Abstract] [Full Text] [Related]
26. Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFR
Abo Al-Hamd MG; Tawfik HO; Abdullah O; Yamaguchi K; Sugiura M; Mehany ABM; El-Hamamsy MH; El-Moselhy TF
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2241674. PubMed ID: 37548154
[TBL] [Abstract][Full Text] [Related]
27. Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practice.
Vingiani A; Lorenzini D; Conca E; Volpi CC; Trupia DV; Gloghini A; Perrone F; Tamborini E; Dagrada GP; Agnelli L; Capone I; Busico A; Pruneri G
Cancer Biomark; 2023; 38(3):301-309. PubMed ID: 37545217
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-Cas9 based knockout of S100A8 in mammary epithelial cells enhances cell proliferation and triggers oncogenic transformation via the PI3K-Akt pathway: Insights from a deep proteomic analysis.
Singh P; Ali SA; Kumar S; Mohanty AK
J Proteomics; 2023 Sep; 288():104981. PubMed ID: 37544501
[TBL] [Abstract][Full Text] [Related]
29. Case report: Clinicopathological and molecular characteristics of pediatric-type follicular lymphoma.
Ren B; Chen Y; Bai X; Zheng J; Chang J; Jiang X; Xia Q; Zhang H
Front Pediatr; 2023; 11():1205384. PubMed ID: 37539011
[TBL] [Abstract][Full Text] [Related]
30. Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
Skorupan N; Ghabra S; Maldonado JA; Zhang Y; Alewine C
J Cancer Metastasis Treat; 2023; 9():. PubMed ID: 37538977
[TBL] [Abstract][Full Text] [Related]
31. Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis.
Hiranuma K; Asami Y; Kato MK; Murakami N; Shimada Y; Matsuda M; Yazaki S; Fujii E; Sudo K; Kuno I; Komatsu M; Hamamoto R; Makinoshima H; Matsumoto K; Ishikawa M; Kohno T; Terao Y; Itakura A; Yoshida H; Shiraishi K; Kato T
Cancer Med; 2023 Sep; 12(17):17835-17848. PubMed ID: 37537783
[TBL] [Abstract][Full Text] [Related]
32. CT-Based Radiogenomics of P4HA3 Expression in Clear Cell Renal Cell Carcinoma.
Greco F; Panunzio A; Tafuri A; Bernetti C; Pagliarulo V; Zobel BB; Scardapane A; Mallio CA
Acad Radiol; 2024 Mar; 31(3):902-908. PubMed ID: 37537130
[TBL] [Abstract][Full Text] [Related]
33. Baseline and early changes in the neutrophil-lymphocyte ratio (NLR) predict survival outcomes in advanced colorectal cancer patients treated with immunotherapy.
Ouyang H; Xiao B; Huang Y; Wang Z
Int Immunopharmacol; 2023 Oct; 123():110703. PubMed ID: 37536184
[TBL] [Abstract][Full Text] [Related]
34. Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian Cancer.
Morton M; Yao M; Chalif J; Lampert EJ; Chau D; Rose PG; Debernardo R; Michener CM; Vargas R; Chambers LM
Obstet Gynecol; 2023 Sep; 142(3):459-466. PubMed ID: 37535957
[TBL] [Abstract][Full Text] [Related]
35. SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC.
An F; Zhang W; Guo Y; Shi F; Kong Y; Tang L; Han C; Wang Q
Aging (Albany NY); 2023 Aug; 15(15):7476-7495. PubMed ID: 37535001
[TBL] [Abstract][Full Text] [Related]
36. Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers.
Xu D; Qian W; Yang Z; Zhang Z; Sun P; Wan Q; Yin Y; Hu Y; Gong L; Zhang B; Yang X; Pu Z; Lu P; Zou J
iScience; 2023 Jul; 26(7):107003. PubMed ID: 37534137
[No Abstract] [Full Text] [Related]
37. Characteristics of glioblastomas and immune microenvironment in a Chinese family with Lynch syndrome and concurrent porokeratosis.
Yao ZG; Hua F; Yin ZH; Xue YJ; Hou YH; Nie YC; Zheng ZM; Zhao MQ; Guo XH; Ma C; Li XK; Wang Z; Liu GC; Zhang GH
Front Oncol; 2023; 13():1194232. PubMed ID: 37529690
[TBL] [Abstract][Full Text] [Related]
38. Highly Sensitive Enrichment of Low-Frequency Variants by Hairpin Competition Amplification.
Liu Z; Zhang R; Jiang X; Ji L; Sun P; Ji Y; Zhang Y; Ding Y; Li K; Pu Z; Zhou F; Zou J
Anal Chem; 2023 Aug; 95(32):12015-12023. PubMed ID: 37527514
[TBL] [Abstract][Full Text] [Related]
39. Exploring the immune microenvironment in small bowel adenocarcinoma using digital image analysis.
Sidi FA; Bingham V; McQuaid S; Craig SG; Turkington RC; James JA; Humphries MP; Salto-Tellez M
PLoS One; 2023; 18(8):e0289355. PubMed ID: 37527282
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
